BackDeep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Overview

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Other Current Liabilities

Latest other current liabilities for DMAQU: $1.2M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$1.20M
49.34% YoYΔ $-1.17M vs prior year quarter

Peer trimmed avg / median

Loading

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Other Current Liabilities History

Loading

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) vs. peers: Other Current Liabilities Comparison

Loading

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) (DMAQU) FAQ

The latest other current liabilities for DMAQU is $1.2M as of June 2026. That compares with $2.4M in the prior-year period — down 49.3% year over year. Investors often review this figure alongside Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, DMAQU's other current liabilities moved from $2.4M to $1.2M — a 49.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s operating scale or balance-sheet position.

A other current liabilities figure of $1.2M for DMAQU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMAQU's other current liabilities ($1.2M), review year-over-year change from $2.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.